BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30548721)

  • 1. External validation of the PREDICT tool in Spanish women with breast cancer participating in population-based screening programmes.
    Aguirre U; García-Gutiérrez S; Romero A; Domingo L; Castells X; Sala M;
    J Eval Clin Pract; 2019 Oct; 25(5):873-880. PubMed ID: 30548721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
    Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
    BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.
    Candido Dos Reis FJ; Wishart GC; Dicks EM; Greenberg D; Rashbass J; Schmidt MK; van den Broek AJ; Ellis IO; Green A; Rakha E; Maishman T; Eccles DM; Pharoah PDP
    Breast Cancer Res; 2017 May; 19(1):58. PubMed ID: 28532503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.
    Maishman T; Copson E; Stanton L; Gerty S; Dicks E; Durcan L; Wishart GC; Pharoah P; ; Eccles D
    Br J Cancer; 2015 Mar; 112(6):983-91. PubMed ID: 25675148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
    Karapanagiotis S; Pharoah PDP; Jackson CH; Newcombe PJ
    Clin Cancer Res; 2018 May; 24(9):2110-2115. PubMed ID: 29444929
    [No Abstract]   [Full Text] [Related]  

  • 12. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
    Winter A; Aberle DR; Hsu W
    Thorax; 2019 Jun; 74(6):551-563. PubMed ID: 30898897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective breast cancer risk prediction model for women undergoing screening mammography.
    Barlow WE; White E; Ballard-Barbash R; Vacek PM; Titus-Ernstoff L; Carney PA; Tice JA; Buist DS; Geller BM; Rosenberg R; Yankaskas BC; Kerlikowske K
    J Natl Cancer Inst; 2006 Sep; 98(17):1204-14. PubMed ID: 16954473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
    Wishart GC; Azzato EM; Greenberg DC; Rashbass J; Kearins O; Lawrence G; Caldas C; Pharoah PD
    Breast Cancer Res; 2010; 12(1):R1. PubMed ID: 20053270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain.
    Arrospide A; Forné C; Rué M; Torà N; Mar J; Baré M
    BMC Cancer; 2013 Dec; 13():587. PubMed ID: 24321553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil.
    Magário MB; Santos RRD; Teixeira LA; Tiezzi DG; Pimentel FF; Carrara HHA; Andrade JM; Reis FJCD
    Braz J Med Biol Res; 2022; 55():e12109. PubMed ID: 36350970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age.
    Yu J; Wu J; Huang O; He J; Zhu L; Chen W; Li Y; Chen X; Shen K
    J Transl Med; 2021 Feb; 19(1):75. PubMed ID: 33593381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancer.
    Ward SE; Holmes GR; Morgan JL; Broggio JW; Collins K; Richards PD; Reed MWR; Wyld L
    Br J Surg; 2020 Nov; 107(12):1625-1632. PubMed ID: 32602959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive model algorithms identifying early and advanced stage ER+/HER2- breast cancer in claims data.
    Beachler DC; de Luise C; Yin R; Gangemi K; Cochetti PT; Lanes S
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):171-178. PubMed ID: 30411431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a breast cancer risk prediction model for Thai women: a cross-sectional study.
    Anothaisintawee T; Teerawattananon Y; Wiratkapun C; Srinakarin J; Woodtichartpreecha P; Hirunpat S; Wongwaisayawan S; Lertsithichai P; Kasamesup V; Thakkinstian A
    Asian Pac J Cancer Prev; 2014; 15(16):6811-7. PubMed ID: 25169530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.